<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Malays J Med Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Malays J Med Sci</journal-id>
<journal-id journal-id-type="publisher-id">Malaysian Journal of Medical Sciences</journal-id>
<journal-title-group>
<journal-title>The Malaysian Journal of Medical Sciences : MJMS</journal-title>
</journal-title-group>
<issn pub-type="ppub">1394-195X</issn>
<issn pub-type="epub">2180-4303</issn>
<publisher>
<publisher-name>Penerbit Universiti Sains Malaysia</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30914877</article-id>
<article-id pub-id-type="pmc">6422567</article-id>
<article-id pub-id-type="doi">10.21315/mjms2018.25.6.4</article-id>
<article-id pub-id-type="publisher-id">04mjms25062018_oa1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Trkb-IP3 Pathway Mediating Neuroprotection in Rat Hippocampal Neuronal Cell Culture Following Induction of Kainic Acid</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chong</surname>
<given-names>Pei Nei</given-names>
</name>
<xref ref-type="aff" rid="af1-04mjms25062018_oa1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sangu</surname>
<given-names>Muthuraju</given-names>
</name>
<xref ref-type="aff" rid="af1-04mjms25062018_oa1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huat</surname>
<given-names>Tee Jong</given-names>
</name>
<xref ref-type="aff" rid="af1-04mjms25062018_oa1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Reza</surname>
<given-names>Faruque</given-names>
</name>
<xref ref-type="aff" rid="af1-04mjms25062018_oa1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Begum</surname>
<given-names>Tahamina</given-names>
</name>
<xref ref-type="aff" rid="af1-04mjms25062018_oa1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yusoff</surname>
<given-names>Abdul Aziz Mohamed</given-names>
</name>
<xref ref-type="aff" rid="af1-04mjms25062018_oa1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jaafar</surname>
<given-names>Hasnan</given-names>
</name>
<xref ref-type="aff" rid="af2-04mjms25062018_oa1">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abdullah</surname>
<given-names>Jafri Malin</given-names>
</name>
<xref ref-type="aff" rid="af1-04mjms25062018_oa1">1</xref>
<xref ref-type="aff" rid="af3-04mjms25062018_oa1">3</xref>
</contrib>
</contrib-group>
<aff id="af1-04mjms25062018_oa1">
<label>1</label>Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia</aff>
<aff id="af2-04mjms25062018_oa1">
<label>2</label>Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia</aff>
<aff id="af3-04mjms25062018_oa1">
<label>3</label>Centre for Neuroscience Services and Research, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia</aff>
<author-notes>
<corresp id="c1-04mjms25062018_oa1">Correspondence: Dr Faruque Reza, Senior Lecturer, PhD (Hokkaido), MBBS (Rajshahi), Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia., Tel: +609 767 6316, Fax: +609 767 3833, E-mail: <email>faruque@usm.my</email>, <email>faruquereza@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>25</volume>
<issue>6</issue>
<fpage>28</fpage>
<lpage>45</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© Penerbit Universiti Sains Malaysia, 2018</copyright-statement>
<copyright-year>2018</copyright-year>
<license>
<license-p>This work is licensed under the terms of the Creative Commons Attribution (CC BY) (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Following brain injury, development of hippocampal sclerosis often led to the temporal lobe epilepsy which is sometimes resistant to common anti-epileptic drugs. Cellular and molecular changes underlying epileptogenesis in animal models were studied, however, the underlying mechanisms of kainic acid (KA) mediated neuronal damage in rat hippocampal neuron cell culture alone has not been elucidated yet.</p>
</sec>
<sec>
<title>Methods</title>
<p>Embryonic day 18 (E-18) rat hippocampus neurons were cultured with poly-L-lysine coated glass coverslips. Following optimisation, KA (0.5 μM), a chemoconvulsant agent, was administered at three different time-points (30, 60 and 90 min) to induce seizure in rat hippocampal neuronal cell culture. We examined cell viability, neurite outgrowth density and immunoreactivity of the hippocampus neuron culture by measuring brain derived neurotrophic factor (BDNF), γ-amino butyric acid A (GABA<sub>A</sub>) subunit α-1 (GABRA1), tyrosine receptor kinase B (TrkB), and inositol trisphosphate receptor (IP<sub>3</sub>R/IP3) levels.</p>
</sec>
<sec>
<title>Results</title>
<p>The results revealed significantly decreased and increased immunoreactivity changes in TrkB (a BDNF receptor) and IP<sub>3</sub>R, respectively, at 60 min time point.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The current findings suggest that TrkB and IP3 could have a neuroprotective role which could be a potential pharmacological target for anti-epilepsy drugs.</p>
</sec>
</abstract>
<kwd-group>
<kwd>rat hippocampal neuron culture</kwd>
<kwd>IP<sub>3</sub> &amp; BDNF-TrkB receptor</kwd>
<kwd>GABA<sub>A</sub> receptor</kwd>
<kwd>kainic acid</kwd>
<kwd>epilepsy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Epilepsy is a brain disorder initiated by the perturbation of ionic equilibrium which results in neuronal hyper-excitability that causes unprovoked and recurrent seizure. This is a common neurological disorder, and various factors such as brain trauma, infection, and genetic factors contribute to its pathogenesis (<xref ref-type="bibr" rid="b1-04mjms25062018_oa1">1</xref>, <xref ref-type="bibr" rid="b2-04mjms25062018_oa1">2</xref>). Seizures in adults and children often affect the hippocampal formation with distinct neuropathological features, including neuronal death, neurogenesis, gliosis, axonal sprouting and reorganisation of neuronal interconnections (<xref ref-type="bibr" rid="b3-04mjms25062018_oa1">3</xref>, <xref ref-type="bibr" rid="b4-04mjms25062018_oa1">4</xref>). These abnormalities typically develop over weeks to years of epileptogenic events, and can occur in healthy tissue after an initial epileptogenic event, such as status epilepticus (<xref ref-type="bibr" rid="b5-04mjms25062018_oa1">5</xref>, <xref ref-type="bibr" rid="b6-04mjms25062018_oa1">6</xref>).</p>
<p>Seizures can be divided into two types: generalised seizures and focal seizures. Generalised seizures involve both hemispheres, whereas focal seizures occur in specific areas of the brain. Seizures can be further divided according to the duration and location of the seizure (<xref ref-type="bibr" rid="b7-04mjms25062018_oa1">7</xref>), and epilepsy can be categorised on the basis of a patient’s age. Epilepsy with earlier onset is typically more detrimental, usually involving ionic changes in γ-amino butyric acid A (GABA<sub>A</sub>) receptors and changes of the balance between excitation and inhibition in the brain (<xref ref-type="bibr" rid="b8-04mjms25062018_oa1">8</xref>). In contrast, epilepsy in adults often exhibits a partial form, and its primary causes are trauma, injury and tumors (<xref ref-type="bibr" rid="b9-04mjms25062018_oa1">9</xref>). However, there are detrimental effects in the hippocampus whenever seizures occur.</p>
<p>To examine the factors underlying epileptogenesis, a number of experiments have been conducted using laboratory simulations in vivo, seeking to replicate the features of a human system. However, neurons exist in the mammalian brain over a subject’s lifetime. Thus, long-term cell culture may provide a useful method for mimicking mammalian physiological processes under laboratory culture conditions (<xref ref-type="bibr" rid="b10-04mjms25062018_oa1">10</xref>). Moreover, neuron culture models have been used to elucidate the molecular mechanisms underlying the development of neuronal polarity and dendritic growth and synapse formation by visualising the subcellular localisation of endogenous protein trafficking (<xref ref-type="bibr" rid="b11-04mjms25062018_oa1">11</xref>). Several types of seizure model are widely used, including chemoconvulsant and electrical kindling models. Pilocarpine and kainic acid (KA) are chemoconvulsant seizure models that can be tested in vitro. Pilocarpine-treated animals exhibit similar electroencephalographic features and neuropathological changes to KA-treated animals (<xref ref-type="bibr" rid="b12-04mjms25062018_oa1">12</xref>). Neuronal, glial and vascular lesions in Pilocarpine and Kainate models of Temporal lobe epilepsy (TLE) has been described in an article of Curia et al. (<xref ref-type="bibr" rid="b13-04mjms25062018_oa1">13</xref>). In previous studies, pilocarpine has mainly been applied via systematic injection, and the hippocampus is often the onset zone, as in the KA model (<xref ref-type="bibr" rid="b12-04mjms25062018_oa1">12</xref>). Importantly, the effects of KA have been validated, contributing to the understanding of the molecular, cellular and pharmacological mechanisms underlying epileptogenesis and ictogenesis (<xref ref-type="bibr" rid="b14-04mjms25062018_oa1">14</xref>).</p>
<p>The KA-induced model has been used to induce epileptogenic symptoms in vivo and in vitro, causing seizure, behavioural changes, oxidative stress, and production of inflammatory mediators (<xref ref-type="bibr" rid="b15-04mjms25062018_oa1">15</xref>). In the current experiment, KA was selected because of its validated simulation of pathological effects, with similar characteristics to the pathology of epilepsy and ischemia (<xref ref-type="bibr" rid="b16-04mjms25062018_oa1">16</xref>, <xref ref-type="bibr" rid="b17-04mjms25062018_oa1">17</xref>). KA has been widely used as a model of epilepsy in both neuronal culture and in vivo models (<xref ref-type="bibr" rid="b12-04mjms25062018_oa1">12</xref>, <xref ref-type="bibr" rid="b18-04mjms25062018_oa1">18</xref>). In addition, it has been reported that epileptogenesis can be caused by changes in homeostatic mechanisms involving calcium (<xref ref-type="bibr" rid="b18-04mjms25062018_oa1">18</xref>). Overloading of glutamate receptor activation by KA receptors induces an influx of cellular Ca<sup>2+</sup>, production of reactive oxygen species (ROS) and mitochondrial dysfunction (<xref ref-type="bibr" rid="b19-04mjms25062018_oa1">19</xref>, <xref ref-type="bibr" rid="b20-04mjms25062018_oa1">20</xref>). Subsequently, Ca<sup>2+</sup> sequestration mechanisms cause neuronal insult and neuronal death, including, hypoxia, ischemia, and epileptic seizures (<xref ref-type="bibr" rid="b14-04mjms25062018_oa1">14</xref>, <xref ref-type="bibr" rid="b18-04mjms25062018_oa1">18</xref>, <xref ref-type="bibr" rid="b19-04mjms25062018_oa1">19</xref>, <xref ref-type="bibr" rid="b20-04mjms25062018_oa1">20</xref>). Importantly, KA was found to trigger neurogenesis, reporting that abnormal maturation of dendrites resulted in the occurrence of seizures. Neurogenesis in hippocampal regions was also found to be related to epileptogenesis (<xref ref-type="bibr" rid="b21-04mjms25062018_oa1">21</xref>).</p>
<p>Several studies have reported that brain derived neurotrophic factor (BDNF) has neuroprotective features, and BDNF mRNA expression has been found to increase after KA exposure (<xref ref-type="bibr" rid="b19-04mjms25062018_oa1">19</xref>, <xref ref-type="bibr" rid="b22-04mjms25062018_oa1">22</xref>, <xref ref-type="bibr" rid="b23-04mjms25062018_oa1">23</xref>). Interestingly, BDNF transgenic mice exhibited reduced seizure behaviour in response to KA under conditions of overexpression of truncated TrkB receptors (<xref ref-type="bibr" rid="b24-04mjms25062018_oa1">24</xref>). In addition, Koyama et al. reported the development of hyper-excitable circuits caused by activity-induced BDNF release and Trk receptor activity. These findings suggested that BDNF enables synaptic plasticity and subsequently elevates N-methyl-D-aspartate receptor (NMDAR) activity via exercise (<xref ref-type="bibr" rid="b25-04mjms25062018_oa1">25</xref>). As an exercise-induced effect, the accumulation of ketone bodies (D-β-hydroxybutyrate; DBHB) in the hippocampus serves both as an energy source and an inhibitor of class I histone deacetylases (HDACs) to specifically induce BDNF expression (<xref ref-type="bibr" rid="b25-04mjms25062018_oa1">25</xref>). In addition, the induction of BDNF expression results in neurogenesis, axonal and dendritic sprouting, and enhanced long-term potentiation (LTP) induction in a TrkB-dependent manner. However, this process can cause hyper-excitability in neurons, eventually resulting in excitotoxicity (<xref ref-type="bibr" rid="b26-04mjms25062018_oa1">26</xref>). Thus, a self-sustaining cycle of sprouting and hyper-excitability is partially fueled by activity-dependent BDNF release, and Trk receptors can precipitate the activation of phospholipase C (PLC), phosphoinositide 3-kinase (PI3K), and Ras, enabling neuronal survival and neurite outgrowth (<xref ref-type="bibr" rid="b27-04mjms25062018_oa1">27</xref>). BDNF regulates synaptic transmission and activity-dependent plasticity, as well as promoting LTP (<xref ref-type="bibr" rid="b26-04mjms25062018_oa1">26</xref>, <xref ref-type="bibr" rid="b27-04mjms25062018_oa1">27</xref>). BDNF-TrkB effects on LTP occur through both pre-and postsynaptic mechanisms, exerting a presynaptic effect in a retrograde manner and a postsynaptic effect by modulating NMDA receptor subunit expression (<xref ref-type="bibr" rid="b28-04mjms25062018_oa1">28</xref>).</p>
<p>During early development of the nervous system, BDNF is also reported to be an essential modulator at postsynaptic sites, including the γ-aminobutyric acid (GABA) type A receptor (GABA<sub>A</sub>R)-mediated signaling that functions in parallel to the neurotrophin/tropomyosin-related kinase (Trk)-dependent, (also known as tyrosine receptor kinase) signaling involved in cell proliferation and migration (<xref ref-type="bibr" rid="b29-04mjms25062018_oa1">29</xref>, <xref ref-type="bibr" rid="b30-04mjms25062018_oa1">30</xref>). As study demonstrated that the TrkB modulating synaptic structure mediates signaling in the hippocampus, reporting that BDNF treatment resulted in an increase in the number of NMDAR and GABA<sub>A</sub>R clusters, and increased the proportion of clusters opposed to the presynaptic terminal (<xref ref-type="bibr" rid="b31-04mjms25062018_oa1">31</xref>). Importantly, BDNF increased the clustering of GABA<sub>A</sub>R under conditions in which TrkB was blocked. TrkB exerts extensively mediated effects on postsynaptic neurotransmitters, to balance out inhibitory and excitatory synaptic transmission as neuronal circuits develop. This issue has been further investigated, revealing a GABAergic synapse deficit in mice with deleted TrkB in the cerebellum, with no changes in the number of glutamatergic synapses (<xref ref-type="bibr" rid="b32-04mjms25062018_oa1">32</xref>, <xref ref-type="bibr" rid="b33-04mjms25062018_oa1">33</xref>).</p>
<p>Particularly in inhibitory GABA<sub>A</sub>R function, BDNF has been found to enhance synaptic responses and facilitate the induction of LTP by eliminating dendritic shunting and eventually promoting transduction of output signals (<xref ref-type="bibr" rid="b34-04mjms25062018_oa1">34</xref>). Researchers have consistently observed the overexpression of BDNF-induced enlargement of soma in GABAergic neurons in cultured E-18 Wistar rat hippocampal neurons. Previous authors have proposed that elevation of GABA<sub>A</sub> and glutamic acid decarboxylase (GAD, GABA synthesising enzyme) facilitates high levels of K<sup>+</sup> and elicits the release of GABA (<xref ref-type="bibr" rid="b35-04mjms25062018_oa1">35</xref>, <xref ref-type="bibr" rid="b36-04mjms25062018_oa1">36</xref>). This suggests that BDNF principally promotes GABAergic maturation, but potentially contributes to excitatory synapse development via increasing resting synaptic vesicles. BDNF treatment has consistently shown an increment of GABA-current amplitude, which is elicited by GABA<sub>A</sub> in hippocampal culture (<xref ref-type="bibr" rid="b37-04mjms25062018_oa1">37</xref>). In accord with this notion, decreased GABA<sub>A</sub>R function in hippocampal regions was found in a patient with medial temporal lobe epilepsy (MTLE) (<xref ref-type="bibr" rid="b38-04mjms25062018_oa1">38</xref>).</p>
<p>BDNF and its receptor TrkB are expressed at a relatively high level in the hippocampus and cerebral cortex, exerting a strong effect on downstream signaling that is critical for epileptogenesis (<xref ref-type="bibr" rid="b39-04mjms25062018_oa1">39</xref>, <xref ref-type="bibr" rid="b40-04mjms25062018_oa1">40</xref>). The TrkB receptor has three downstream signaling pathways involving BDNF binding: phosphatidyl (PI3K), phopholipase Cγ (PLCγ) and mitogen activated protein kinases/extracellular signal-regulated kinases (MAPK/ERK), these pathways can lead to neurogenesis and synaptic plasticity, as suggested in previous studies (<xref ref-type="bibr" rid="b33-04mjms25062018_oa1">33</xref>, <xref ref-type="bibr" rid="b41-04mjms25062018_oa1">41</xref>, <xref ref-type="bibr" rid="b42-04mjms25062018_oa1">42</xref>, <xref ref-type="bibr" rid="b43-04mjms25062018_oa1">43</xref>). However, it has been proposed that the PLCγ pathway may be involved in epileptogenic seizure (<xref ref-type="bibr" rid="b44-04mjms25062018_oa1">44</xref>). One of the products of PLCγ, inositol 1, 4, 5 trisphosphate (IP3) has the ability to mobilise intracellular Ca<sup>2+</sup> (<xref ref-type="bibr" rid="b34-04mjms25062018_oa1">34</xref>, <xref ref-type="bibr" rid="b44-04mjms25062018_oa1">44</xref>, <xref ref-type="bibr" rid="b45-04mjms25062018_oa1">45</xref>, <xref ref-type="bibr" rid="b46-04mjms25062018_oa1">46</xref>). Several studies have reported that the mobilisation of calcium ions suppresses GABA<sub>A</sub>R function, resulting in epileptogenic seizure (<xref ref-type="bibr" rid="b29-04mjms25062018_oa1">29</xref>, <xref ref-type="bibr" rid="b37-04mjms25062018_oa1">37</xref>, <xref ref-type="bibr" rid="b41-04mjms25062018_oa1">41</xref>). Moreover, application of KA to hippocampal neuronal culture is speculated to elevate the production of free radicals in the intracellular Ca<sup>2+</sup>, which specifically triggers production of IP3 and PLC<sub>γ</sub>, eventually affecting IP3R and likely leading to suppression of GABA<sub>A</sub>R because of the over-excitation of GluR5 receptors (kainate receptors). However, it remains unclear why IP3 is an indicator of the suppression of GABA<sub>A</sub>R and downstream BDNF-TrkB.</p>
<p>In the present study, GABAR, BDNF, TrkB, IP3, and IP3R were assessed to investigate the difference of these receptors in normal and epileptogenic hippocampal neuron culture. These receptors were highlighted as important components with significant responses to KA-induced seizure in previous research (<xref ref-type="bibr" rid="b34-04mjms25062018_oa1">34</xref>, <xref ref-type="bibr" rid="b39-04mjms25062018_oa1">39</xref>, <xref ref-type="bibr" rid="b40-04mjms25062018_oa1">40</xref>, <xref ref-type="bibr" rid="b44-04mjms25062018_oa1">44</xref>).</p>
<p>Therefore, in the current study we examined changes in GABA<sub>A</sub> receptors, BDNF-TrkB receptors and IP3 receptors in normal and epileptogenic primary rat hippocampal neuron culture at embryonic day 18 (E-18), to elucidate the mechanisms of epileptogenic seizure and provide insights for anti-epilepsy drug (AED) development.</p>
</sec>
<sec sec-type="materials|methods">
<title>Material and Methods</title>
<sec>
<title>Cell Culture</title>
<p>Primary rat hippocampal neuron (PRHN; A104841-01) was purchased from Gibco™, USA. PRHN was isolated from day-18 Fischer 344 rat embryos, then cultured using the Neurobasal®-medium (Gibco™, 21103049) supplemented with GlutaMAXTM-I Supplement (Gibco™, 35050061) and B-27® Serum Free Supplement (Gibco™, 17504044) with proportions based on the protocol provided by the manufacturer. In addition, L-glutamine (Gibco™, 25030081) was supplemented for the first 4 days of culturing in accord with the manufacturer’s suggested protocol. The PRHN was plated with a neuronal density of 900 cells/mm<sup>2</sup> which have a maturity rate that suits our experiment design (<xref ref-type="bibr" rid="b45-04mjms25062018_oa1">45</xref>). PRHN was cultured on a culture plate coated with 0.01% poly-L-lysine (Sigma-Aldrich, 25988-63-0): molecular weight-70000–150000 according to the coating method described by Todd et al. (<xref ref-type="bibr" rid="b10-04mjms25062018_oa1">10</xref>). The cells were cultured in incubator at a temperature of 36 °C–38 °C with 5% CO<sub>2</sub>. The culture was maintained, aspirating half of the media from each well and replacing it with fresh composite media every third day.</p>
</sec>
<sec>
<title>Kainic Acid Treatment</title>
<p>KA (Sigma-Aldrich, 58002-62-3) 10 mg was added to 1 mL of Dulbecco’s phosphate-buffered saline (DPBS) (Gibco™, 14040117). Serial dilution was then performed using DPBS (Gibco™, 14040117) to obtain 0.5 μM KA. Next, 0.5 μM KA was added to the cultured PRHN and incubated for 30, 60 or 90 min.</p>
</sec>
<sec>
<title>Morphological Assessment</title>
<p>To examine the morphological changes of PRHN along the culturing period, we captured digital images of cultured cells in non-overlapping fields using phase contrast microscopy (Axiovert 200) to examine cell morphology for structural alterations in cell bodies, neurites and cellular interconnection.</p>
</sec>
<sec>
<title>Cell Viability Testing</title>
<p>We used a neurite outgrowth staining kit (Invitrogen™, A15001) to examine the viability and health of cells. The PRHN was plated in a 96-well cell culture plate with 3.0 × 104 neurons per well, then stained with neurite outgrowth staining after KA treatment. Neurite outgrowth staining containing a cell viability indicator, and cell membrane staining, which emit green fluorescence and bright red orange fluorescence, respectively. The fluorescence intensity of the stained cells was assessed using a microplate reader VariosKan 2000 and SkanIt™ Software. Bottom-read fluorescence detection was performed using monochromator excitation/emission setting 483/525 nm (12 nm bandwidth) for green fluorescence cell viability indicator and 554/567 nm (5 nm bandwidth) for the orange-fluorescent cell membrane stain. Cell-free controls were included and used for background subtraction. Cell treatments were typically performed in triplicate, and the mean ± standard error of the mean (SEM) was plotted using GraphPad Prism 7™ software.</p>
</sec>
<sec>
<title>Immunocytochemistry</title>
<p>To examine the immunoreactivity of BDNF, TrkB, GABRA1 and IP3, PRHN was plated in a 6-well plate with 25 mm round glass coverslips coated with poly-L-lysine. PRHN was plated with 1.8 × 105 cells in each well, and incubated at 36 °C–38 °C in a humidified atmosphere of 5% CO<sub>2</sub> in incubator (<xref ref-type="bibr" rid="b10-04mjms25062018_oa1">10</xref>). The different treatment groups underwent cell fixation with 4% paraformaldehyde (PFA) for 15 min. The cells were rinsed with DPBS (with Ca<sup>2+</sup> and Mg<sup>2+</sup>) twice and permeabilised with 0.3% Triton-X (diluted in DPBS with Ca<sup>2+</sup> and Mg<sup>2+</sup>) for 15 min at room temperature. Following several washes in DPBS with Ca<sup>2+</sup> and Mg<sup>2+</sup>, cells were incubated in blocking solution (5% goat serum solution in DPBS with Ca<sup>2+</sup> and Mg<sup>2+</sup>) for 2 h at room temperature and incubated with primary monoclonal antibodies against BDNF (1:1000; Abcam, UK), TrkB (10:1000; Abcam, UK), GABRA1 (1:1000; Abcam, UK), IP3 (1:1000; Abcam, UK), respectively overnight at 4 °C. The following day, cells were washed several times in DPBS with Ca<sup>2+</sup> and Mg<sup>2+</sup>. Goat anti-mouse IgG (H+L) highly cross-adsorbed secondary antibody conjugated with Alexa Fluor 488 (Life Technologies, USA) or goat anti-rabbit IgG (H+L) highly cross-adsorbed secondary antibody conjugated with Alexa Fluor 594 (Life Technologies, USA) diluted in antibody diluent was added at a ratio of 1:1000 and incubated at room temperature for 2 h. Cells were washed with DPBS with Ca<sup>2+</sup> and Mg<sup>2+</sup> for 5 min each, and a small drop of Prolong® Gold anti-fade reagent was added, cover slipped, and used for microscopic analysis. Microscopic images were captured using EVOS FL Auto 2 Cell Imaging System (Thermo Fisher Scientific, USA), and quantification of cell fluorescence intensity was carried out using ImageJ software (Version 1.46; NIH, USA) (<xref ref-type="bibr" rid="b47-04mjms25062018_oa1">47</xref>, <xref ref-type="bibr" rid="b48-04mjms25062018_oa1">48</xref>). There were more than five figures taken to analysis each and every groups of neuronal cells. The figures were taken randomly in cell culture flask.</p>
</sec>
<sec sec-type="methods">
<title>Statistical Analysis</title>
<p>Two independent experiments were carried out in triplicate for cell viability analysis and immunocytochemistry. All data are presented as mean ± SEM. For statistical comparison between different treatment groups, Analysis of variance (ANOVA) with Bonferroni’s test was used. Significant differences are indicated by asterisks in the figures (*<italic>P</italic> &lt; 0.05; <italic>**P</italic> &lt; 0.001).</p>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Morphological Changes in Hippocampal Neuron Culture</title>
<p>Changes in hippocampal neuron culture, such extension of dendrites and the connectivity of neurons, can be observed with light microscopy. The captured images are shown in <xref ref-type="fig" rid="f1-04mjms25062018_oa1">Figure 1</xref>. E-18 hippocampal neurons were cultured for up to 21 days, and images were captured every 3 days to observe morphological changes. The results revealed that cells began to emit neurites after a few hours of plating. Neurites emerged gradually from the dark spot representing the neuron, observed under 10× magnifications with an inverted microscope. In addition, we observed changes in the culture media using phenol red as indicator of change from pinkish-red media to golden culture media after the first 24 h of incubation. At DIV 1 onward, the sprouting of dendrites became denser as the culture continued, and the connections of neurons became more intense. The cellular stages of maturity are indicated by dendritic and axonal formation (<xref ref-type="bibr" rid="b49-04mjms25062018_oa1">49</xref>). At DIV 21, the network of dendrites was complex, and the cells were mature. These results are in accord with previous cell culture studies in which differentiated neurons developed extensive axonal and dendritic arbors and formed numerous functional connections with one another (<xref ref-type="bibr" rid="b10-04mjms25062018_oa1">10</xref>, <xref ref-type="bibr" rid="b11-04mjms25062018_oa1">11</xref>, <xref ref-type="bibr" rid="b47-04mjms25062018_oa1">47</xref>).</p>
</sec>
<sec>
<title>Morphological Changes of E-18 Rat Hippocampal Neuronal Culture Following KA Exposure</title>
<p>To examine the time course and localisation of KA-induced neuronal damage in vitro, hippocampal neuron cultures were treated with 0.5 μM of KA for various times (30 min, 60 min and 90 min) at the peak of neuron characterisation DIV-12 (<xref ref-type="bibr" rid="b47-04mjms25062018_oa1">47</xref>). As shown in <xref ref-type="fig" rid="f1-04mjms25062018_oa1">Figure 1B</xref>, neurite extension and the networking of dendrites were reduced compared with the control group. After 90 min of KA exposure in hippocampal neuron culture, the floating debris in the media increased and the shape of the neurons indicated shrinking with truncated dendrites. The flotation of debris is a sign of neuronal detachment from the culture surface due to a loss of adhesion to the culture floor.</p>
</sec>
<sec>
<title>Cell Viability and Neurite Outgrowth Density</title>
<p>To identify changes in neurons following KA exposure, we quantified cell viability and neuronal outgrowth of living cells using the cell viability indicator in the neurite outgrowth kit (Thermo Fisher Scientific, US). The average intensity of cell viability labeling showed no significant differences (F [3, 32] = 1.585, <italic>P =</italic> 0.2123; α = 0.05). However, the graph of cell viability (RFU) of neuronal culture (<xref ref-type="fig" rid="f2-04mjms25062018_oa1">Figure 2A</xref>) showed a trend towards different cellular responses to KA treatment for 30, 60 and 90 min, compared with the control group. KA1 showed no changes of cell viability compared with controls (0.0222 ± 0.0029, <italic>P &gt;</italic> 0.99), while cell viability of the cell incubator for 60 min (KA2) showed a mild decrement (0.0211 ± 0.0032, <italic>P &gt;</italic> 0.05). In contrast, cell viability of KA3 showed a slight increase (0.0242 ± 0.0037, <italic>P &gt;</italic> 0.05).</p>
<p>We conducted another assessment using the neurite outgrowth kit (Thermo Scientific, USA), which provides a measure of neurite outgrowth density (RFU units). The average neurite outgrowth density showed no significant effects in the neuronal culture after 30, 60 and 90 min of KA incubation (F [3, 32] = 0.5719, <italic>P =</italic> 0.6376, α = 0.05). Although there were no significant effects, <xref ref-type="fig" rid="f2-04mjms25062018_oa1">Figure 2B</xref> shows a trend towards a decrement of neurite density over time. In addition, the data indicated a slight but non-significant reduction in neurites of the cell as the incubation time increased: KA1 (638.7 ± 37.1, <italic>P &gt;</italic> 0.05); KA2 (634.7 ± 33.74, <italic>P &gt;</italic> 0.05); KA3 (632.8 ± 29.35, <italic>P &gt;</italic> 0.05). Although this decrement was not significant, the trend suggests that KA may have affected the neurite or dendrite extension in the cell, reducing the level of fluorescence emitted.</p>
</sec>
<sec>
<title>Expression of BDNF, TrkB, IP3 and GABRA1</title>
<p>Immunostaining was conducted in the normal and epileptogenic hippocampal neuronal culture. BDNF and GABRA1 receptors were stained with Alexa Fluor 488, which emits green light when the fluorescence beam is bombarded. BDNF was found to be located extracellularly, scattered around the cell as shown in <xref ref-type="fig" rid="f3-04mjms25062018_oa1">Figure 3A</xref>. Meanwhile, anti-TrkB (<xref ref-type="fig" rid="f4-04mjms25062018_oa1">Figure 4A</xref>) and anti-IP3 (<xref ref-type="fig" rid="f5-04mjms25062018_oa1">Figure 5A</xref>) were stained with red using Alexa Fluor 593. In addition, anti-GABRA1 receptors (<xref ref-type="fig" rid="f6-04mjms25062018_oa1">Figure 6A</xref>) were also found in the neurons in which green was expressed in the image.</p>
</sec>
<sec>
<title>Expression of BDNF Following KA Treatment</title>
<p>KA treatment-related changes in BDNF immunofluorescence intensity were quantified from the images (<xref ref-type="fig" rid="f3-04mjms25062018_oa1">Figure 3A</xref>) of the hippocampal neuronal culture and compared with KA non-treated cell culture as a control. The level of the BDNF signal was not significantly influenced by KA treatment at 30, 60 and 90 min (F [3, 8] = 1.145, <italic>P &gt;</italic> 0.05). However, inhibition was observed at KA1 (2.409 ± 0.7357, <italic>P &gt;</italic> 0.05) and KA2 (2.712 ± 2.325, <italic>P &gt;</italic> 0.05) followed by an increment at KA3 (4.603 ± 1.299, <italic>P &gt;</italic> 0.05) (<xref ref-type="fig" rid="f3-04mjms25062018_oa1">Figure 3B</xref>).</p>
</sec>
<sec>
<title>Expression of TrkB Following KA Treatment</title>
<p>KA treatment-related changes in TrkB immunofluorescence intensity were quantified from the images (<xref ref-type="fig" rid="f4-04mjms25062018_oa1">Figure 4A</xref>) of the hippocampal neuronal culture and compared with KA non-treated cell culture as a control. The level of TrkB fluorescence intensity was significantly decreased by KA treatment at 30, 60 and 90 min (F [3, 8] = 1.145, <italic>P =</italic> 0.010, α = 0.05). The number of TrkB particles at KA1 (30 min of KA incubation) and KA2 (60 min of KA incubation) exhibited a slight non-significant decrease (370.3 ± 89.63, <italic>P =</italic> 0.050), and a significant decrease (340.3 ± 20.82, <italic>P =</italic> 0.030*), respectively. At 90 min of KA incubation, KA3 exhibited a significant reduction of particles (195.7 ± 76.7, <italic>P &lt;</italic> 0.01**). The TrkB immunofluorescence intensity (<xref ref-type="fig" rid="f4-04mjms25062018_oa1">Figure 4B</xref>) and the number of particles (<xref ref-type="fig" rid="f4-04mjms25062018_oa1">Figure 4C</xref>) are correlated.</p>
</sec>
<sec>
<title>Expression of IP3R Following KA Treatment</title>
<p>As shown in <xref ref-type="fig" rid="f5-04mjms25062018_oa1">Figure 5A</xref>, KA treatment-related changes in IP3R immunofluorescence intensity were quantified from images in the hippocampal neuronal culture, and compared with KA non-treated cell culture as a control. The IP3R signal was significantly affected by KA treatment (F [3, 8] = 6.954, <italic>P =</italic> 0.049, α = 0.05). IP3R was significantly expressed at KA2 (7.045 ± 1.338, <italic>P &lt;</italic> 0.05). The results indicated an increment of IP3R, suggesting that downstream BDNF, TrkB and/or GABRA1 were triggered in the KA-treated neuron culture. The IP<sub>3</sub>R immunofluorescence intensity (<xref ref-type="fig" rid="f5-04mjms25062018_oa1">Figure 5B</xref>) and the number of particles (<xref ref-type="fig" rid="f5-04mjms25062018_oa1">Figure 5C</xref>) are correlated except at KA3.</p>
</sec>
<sec>
<title>Expression of GABA<sub>A</sub>R α-1/GABRA1 Following KA Treatment</title>
<p>The KA treatment-related changes in GABRA1 immunofluorescence intensity were quantified from the images (<xref ref-type="fig" rid="f6-04mjms25062018_oa1">Figure 6A</xref>) of the hippocampal neuronal culture, and compared with KA non-treated cell cultures as a control. The level of the GABRA1 signal was not significantly influenced by KA treatment at 30, 60 and 90 min (F [3, 8] = 1.178, <italic>P =</italic> 0.372; α = 0.05) as shown in <xref ref-type="fig" rid="f6-04mjms25062018_oa1">Figure 6B</xref>. However, although no significant decrement was found, the imaging data indicates a trend towards declining intensity in images captured from immune-stained neuron cultures. The GABRA1 immunofluorescence intensity (<xref ref-type="fig" rid="f6-04mjms25062018_oa1">Figure 6B</xref>) and the number of particles (<xref ref-type="fig" rid="f6-04mjms25062018_oa1">Figure 6C</xref>) are correlated.</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In the present study, to reveal the time course and localisation of KA-induce neuronal damage in vitro, cultured hippocampal neurons were treated with 0.5 μM of KA at various times (30 min, 60 min and 90 min), followed by neurite outgrowth and cell viability assay. The neurite outgrowth cell viability assay is considered important for examining the morphological phenotype of neuron culture and cell health (<xref ref-type="bibr" rid="b50-04mjms25062018_oa1">50</xref>). Moreover, this staining kit also determines neurite outgrowth density, rapidly isolating rat cortex neurons and iPSC-derived iCell neurons and PC-12 derived neuroscreen-1 cells, using an unbiased microplate reader with two different coloured dyes (cell membrane stain and cell viability indicator) and a background suppression dye (<xref ref-type="bibr" rid="b50-04mjms25062018_oa1">50</xref>). This method is faster than a previous method for assessing neurite outgrowth density by immunocytochemical staining (beta-III tubulin or MAP2) followed by manual or automated microscopic image acquisition and analysis (<xref ref-type="bibr" rid="b51-04mjms25062018_oa1">51</xref>, <xref ref-type="bibr" rid="b52-04mjms25062018_oa1">52</xref>). However, this immunocytochemistry technique is still required for identifying the morphological features, particularly parameters such as neurite length, soma size and neurite complexity (<xref ref-type="bibr" rid="b53-04mjms25062018_oa1">53</xref>).</p>
<p>The present study demonstrated that KA treatment induced a neurodegenerative effect in embryonic rat hippocampal neuron culture. Morphological changes were detected, including disrupted dendritic arbor development and truncated dendrites after KA incubation. These are early indicators of neurodegeneration, demonstrating that neurons had begun to lose dendrites, cell bodies appeared to shrink, and cytoplasmic material was lost and detached from neighboring cells or the culture surface (<xref ref-type="bibr" rid="b54-04mjms25062018_oa1">54</xref>, <xref ref-type="bibr" rid="b55-04mjms25062018_oa1">55</xref>). Previous studies suggested that KA caused damage to the cell body and degeneration in the nucleus, causing darkening in color and truncated dendrites as early cellular changes in response to toxic insult (<xref ref-type="bibr" rid="b56-04mjms25062018_oa1">56</xref>). However, in the current study, there was significant difference in cell viability and neurite outgrowth density of the hippocampal neuron culture between normal and KA-treated neurons at 60 min whereas compared with 90 min did not. The underlying mechanisms need to be elucidated.</p>
<p>Transformations from excitatory to inhibitory activity were observed in the present study. Quantification of immunoreactivity was not detected in particle count, possibly because of the transformation of excitatory to inhibitory activity in GABRA1 in the maturation of neurons. Alterations of excitatory and inhibitory interneurons are substantially diminished in the sclerotic hippocampus and following status epilepticus (SE) seizures (<xref ref-type="bibr" rid="b55-04mjms25062018_oa1">55</xref>, <xref ref-type="bibr" rid="b57-04mjms25062018_oa1">57</xref>). During the early stages after SE, dramatic changes occur in the hippocampus, including cerebral edema and compensatory changes, as demonstrated by 1H-MR spectroscopy soon after injury in vivo. An early decrease of glutamate levels and increased GABA levels at 8 days onwards indicates progressive development of hippocampal neurodegeneration (<xref ref-type="bibr" rid="b57-04mjms25062018_oa1">57</xref>). Studies of the effects of elevated BDNF in GABAergic neurons have indicated that BDNF decreases GABAergic transmission and decreases K-Cl transporter (KCC2) activity (<xref ref-type="bibr" rid="b58-04mjms25062018_oa1">58</xref>). Upregulation of GAD-expressing interneurons has been identified after KA (<xref ref-type="bibr" rid="b59-04mjms25062018_oa1">59</xref>). Compensatory mechanisms occur before refractory seizure because of upregulation of GAD67 in granule cells (<xref ref-type="bibr" rid="b56-04mjms25062018_oa1">56</xref>). In developing neurons, protein tyrosine kinases are essential in mediating the switch of GABAergic inhibition, and disruption of a specific subtype of KCC2 has been found to increase seizure susceptibility in young and adult animals (<xref ref-type="bibr" rid="b60-04mjms25062018_oa1">60</xref>). Loss of GABAergic neurons inhibits neuronal excitability by downregulating the BDNF-TrkB signaling pathway after practicing treadmill exercise in epileptic rats.</p>
<p>Moreover, a study using a theta-burst stimulation (TBS)-induced model reported that activation of metabotropic glutamate receptors (mGluRs) is involved in KCC2 in cortical neurons, leading to increased intracellular Ca<sup>2+</sup> (<xref ref-type="bibr" rid="b61-04mjms25062018_oa1">61</xref>). GABA<sub>A</sub>R may also be affected by the GluR5 kainate receptor after KA treatment. GluR5 is one of the kainate receptors located in the CA1 and CA3 subfields (<xref ref-type="bibr" rid="b14-04mjms25062018_oa1">14</xref>, <xref ref-type="bibr" rid="b62-04mjms25062018_oa1">62</xref>). One previous study revealed that GluR5 knockout mice exhibit increased epileptogenic activity, whereas knockout of GluR6 prevents the induction of epileptogenic activity (<xref ref-type="bibr" rid="b63-04mjms25062018_oa1">63</xref>). In addition, upregulation of GluR5 mRNA levels occurs in the hippocampus when KA is administered (<xref ref-type="bibr" rid="b63-04mjms25062018_oa1">63</xref>). Thus, the decrease of GABRA1 could be the result of upregulation of mGLuR5 after KA treatment. A review of GABAR and mGluR5 signaling in the cerebellum in patients with schizophrenia, mood disorders, and autism reported that GABRA1 is affected by mGluR5 (<xref ref-type="bibr" rid="b64-04mjms25062018_oa1">64</xref>). However, molecular cascades should be studied in more depth to elucidate the relationship between mGLUR5 and GABRA1. A study reported that the function of GABAergic neurons is usually conserved in absence epilepsy and GABAergic inhibition is considered to potentiate clinical and experimental seizure initiation (<xref ref-type="bibr" rid="b66-04mjms25062018_oa1">66</xref>). The different role of GABAA and GABAB receptors reported that spike and wave discharges (SWD) related activity occurred without significant contribution of GABAB receptors but inhibit of GABAA receptors potentiates SWD related activity (<xref ref-type="bibr" rid="b67-04mjms25062018_oa1">67</xref>). GABAA and GABAB receptors activation differently regulated spindle like rhythmic activity in seizure (<xref ref-type="bibr" rid="b68-04mjms25062018_oa1">68</xref>). Another previous study demonstrated that rhythmic inhibitory potentials through GABAA but not GABAB receptor activation during seizure in thalamocortical neurons (<xref ref-type="bibr" rid="b69-04mjms25062018_oa1">69</xref>).</p>
<p>BDNF and its receptors have been implicated in the development of epilepsy. Conditioned media can protect hippocampal neurons against KA-induced excitotoxicity, stimulating endogenous cell survival factors BDNF and anti-apoptotic Bcl-2 in the host cell (<xref ref-type="bibr" rid="b19-04mjms25062018_oa1">19</xref>). In addition, increased seizure activity has been found to upregulate BDNF mRNA and protein expression in immunoreactivity, and to activate TrkB in the epileptic brain (<xref ref-type="bibr" rid="b22-04mjms25062018_oa1">22</xref>, <xref ref-type="bibr" rid="b28-04mjms25062018_oa1">28</xref>, <xref ref-type="bibr" rid="b36-04mjms25062018_oa1">36</xref>, <xref ref-type="bibr" rid="b65-04mjms25062018_oa1">65</xref>, <xref ref-type="bibr" rid="b66-04mjms25062018_oa1">66</xref>). BDNF knockout mice have been reported to exhibit overexpression of TrkB in response to KA (<xref ref-type="bibr" rid="b24-04mjms25062018_oa1">24</xref>, <xref ref-type="bibr" rid="b67-04mjms25062018_oa1">67</xref>). BDNF signal modifies epileptogenesis, as reviewed by Lähteinen et al. (<xref ref-type="bibr" rid="b72-04mjms25062018_oa1">72</xref>), however, previous studies reported that BDNF showed no significant change in immunoreactivity in KA-treated hippocampal neuron culture. In addition, p75NTR and proBDNF would be expected to act as prior upregulated proteins in KA-treated neurons because they are released in apoptosis and necrosis after seizure or TrkB receptor binding and activation of ERK, and neurite outgrowth is reported to cease after prolonged p75NTR activation and apoptosis in neurons (<xref ref-type="bibr" rid="b28-04mjms25062018_oa1">28</xref>, <xref ref-type="bibr" rid="b58-04mjms25062018_oa1">58</xref>). Upregulation of p75NTR was found in the hippocampus following chemoconvulsant seizure (using KA and pilocarpine), with elevation of immunoreactivity in neurons and astrocytes (<xref ref-type="bibr" rid="b73-04mjms25062018_oa1">73</xref>, <xref ref-type="bibr" rid="b74-04mjms25062018_oa1">74</xref>). The seizure activity increases the excitability of primary cells, increasing the likelihood of epileptogenesis via morphological changes in dendritic spine, and stimulating axonal growth. This notion is supported by the finding of significant upregulation of BDNF and TrkB immunoreactivity in hippocampal neurons (in dentate gyrus and CA3) but no clear difference between patients with hippocampal sclerosis and those without hippocampal sclerosis (<xref ref-type="bibr" rid="b69-04mjms25062018_oa1">69</xref>). Turnover of hippocampal neurons rather than neurogenesis per se and BDNF signaling are required for the long-term survival of newborn neurons in the mouse hippocampus (<xref ref-type="bibr" rid="b57-04mjms25062018_oa1">57</xref>). One previous study reported that epileptogenesis was was initiated by excitability rather than being triggered by axonal spouting (<xref ref-type="bibr" rid="b27-04mjms25062018_oa1">27</xref>). This disparity is thought to indicate that chronic infusion of BDNF can downregulate TrkB receptors (<xref ref-type="bibr" rid="b75-04mjms25062018_oa1">75</xref>). In addition, downregulation of TrkB can ameliorate some conditions in which BDNF is elevated. However, this highlights the complexity of the issue, because BDNF does not always decrease TrkB. In addition, TrkB can be moved to a different cellular compartment, potentially playing new functional roles. Trk and p75 neurotrophic receptor (p75NTR)-containing vesicles are linked to axonal transport processes (<xref ref-type="bibr" rid="b76-04mjms25062018_oa1">76</xref>). Activation of secondary receptors, in which p75NTR modulates Trk receptor binding, mediates the activation of ERK from RAS, and neurite outgrowth activates c-jun N terminal kinase leading to apoptosis and triggering the secondary messenger MAP/ERK pathway, involving proto-oncogene c-fos and nitric oxide (NO)-producing neurons (<xref ref-type="bibr" rid="b77-04mjms25062018_oa1">77</xref>).</p>
<p>Our experiments consistently indicated that TrkB receptors were significantly reduced after KA was introduced into cultured neurons. We speculate that TrkB can cause transient inhibition to prevent recurrent seizure, exerting a neuroprotective effect. This thought is in line of the previous study that activation of TrkB protects neurons from dying (<xref ref-type="bibr" rid="b78-04mjms25062018_oa1">78</xref>). Eventually, the promotion of epilepsy by excessive TrkB kinase could also be prevented by uncoupling TrkB from the main signaling pathway of PLCγ1 (<xref ref-type="bibr" rid="b79-04mjms25062018_oa1">79</xref>). Phosphorylation of N-shC and PLCγ1 occurs after docking to Trk receptors, and PLCγ1 catalyses the breakdown to inositol 1,4,5 triphosphate, increasing Ca<sup>2+</sup> in intracellular storage and DAG regulates protein kinase C (<xref ref-type="bibr" rid="b28-04mjms25062018_oa1">28</xref>). A study demonstrated that neuronal loss in the hippocampus by KA-induced epileptiform activity was mediated by the N-SHC signaling pathway (<xref ref-type="bibr" rid="b80-04mjms25062018_oa1">80</xref>). The current results suggest that IP3R activity is eventually affected, and that increased immunoreactivity of IP3R could be caused by intracellular Ca<sup>2+</sup> release.</p>
<p>The upregulation of IP3R might have been caused by oxidative stress following KA treatment. Neuroexcitotoxicity properties were exhibited when KA was bound to kainite receptors (<xref ref-type="bibr" rid="b15-04mjms25062018_oa1">15</xref>). The overactivation of kainite receptors produces neuronal membrane depolarisation, causing excessive influx of Ca<sup>2+</sup> into the neuron. In turn, this process disrupts the equilibrium of antioxidants and increases intracellular Ca<sup>2+</sup> production of free radicals, resulting in oxidative stress in the neurons (<xref ref-type="bibr" rid="b15-04mjms25062018_oa1">15</xref>). The occurrence of oxidative stress suggests the presence of neuronal and glial death due to vulnerability of the brain in response to oxygen and glucose (<xref ref-type="bibr" rid="b15-04mjms25062018_oa1">15</xref>, <xref ref-type="bibr" rid="b76-04mjms25062018_oa1">76</xref>). ROS are a mediator of oxidative stress, acting as oxidant agents that oxidise membrane lipids, protein, and DNA. As levels of ROS increase, a range of neurodegenerative agents also increases, including superoxide anions (O<sub>2</sub><sup>−</sup>), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and highly reactive hydroxyl radicals (<sup>·</sup>HO) (<xref ref-type="bibr" rid="b76-04mjms25062018_oa1">76</xref>). Increases in these agents can lead to necrosis and apoptosis (<xref ref-type="bibr" rid="b81-04mjms25062018_oa1">81</xref>).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In the present study concluded that KA induced neuronal damage within 30 min of exposure. The neuronal damage could mediate through TrkB-IP3 pathway as shown in the results. BDNF and GABA receptors did not show any significant changes as compared with control. In contrast, in the animal study reported that BDNF expression was increased after KA induction. As in the in vitro model with only neuron culture, BDNF did not change. The results suggested that the KA mediation of neuronal damage not dependent GABA or BDNF activation. The mechanism underlying TrkB-IP3 mediated neuroprotection need to be studied. However, the present finding strongly suggested that TrkB-IP3 could be important pathway to elucidate in future.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank SFN (Kelantan Chapter) for the sponsorship. We also would like to thank Benjamin Knight, MSc, from Edanz Group (<ext-link ext-link-type="uri" xlink:href="www.edanzediting.com/ac">www.edanzediting.com/ac</ext-link>) for editing the draft of this manuscript.</p>
</ack>
<fn-group>
<fn fn-type="COI-statement" id="fn1-04mjms25062018_oa1">
<p>
<bold>Conflicts of Interest</bold>
</p>
<p>None.</p>
</fn>
<fn id="fn2-04mjms25062018_oa1">
<p>
<bold>Funds</bold>
</p>
<p>This research was supported by Fundamental Research Grant Scheme (FRGS) [ref: 203/PPSP/6171175] from Ministry of Higher Education (MOHE) for the authors’ FR.</p>
</fn>
<fn id="fn3-04mjms25062018_oa1">
<p>
<bold>Authors’ Contributions</bold>
</p>
<p>Conception and design: FR</p>
<p>Analysis and interpretation of the data: PNC</p>
<p>Drafting of the article: PNC</p>
<p>Critical revision of the article for important intellectual content: TB, AAMY, HJ, JMA</p>
<p>Final approval of the article: TB, AAMY</p>
<p>Provision of study materials or patients: TJH, MS</p>
<p>Obtaining of funding: FR</p>
<p>Administrative, technical, or logistic support: HJ, JMA</p>
<p>Collection and assembly of data: PNC, TJH, MS</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-04mjms25062018_oa1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lytton</surname>
<given-names>WW</given-names>
</name>
</person-group>
<article-title>Computer modelling of epilepsy</article-title>
<source/>Nat Rev Neurosci
          <year>2008</year>
<volume>9</volume>
<issue>8</issue>
<fpage>626</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2416</pub-id>
<pub-id pub-id-type="pmid">18594562</pub-id>
</element-citation>
</ref>
<ref id="b2-04mjms25062018_oa1">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dargham</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activation of extrasynaptic GABA<sub>A</sub> receptors inhibits cyclothiazide-induced epileptiform activity in hippocampal CA1 neurons</article-title>
<source/>Neurosci Bull
          <year>2014</year>
<volume>30</volume>
<issue>5</issue>
<fpage>866</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="doi">10.1007/s12264-014-1466-8</pub-id>
<pub-id pub-id-type="pmid">25260800</pub-id>
</element-citation>
</ref>
<ref id="b3-04mjms25062018_oa1">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Treiman</surname>
<given-names>DM</given-names>
</name>
</person-group>
<article-title>GABAergic mechanisms in epilepsy</article-title>
<source/>Epilepsia
          <year>2001</year>
<volume>42</volume>
<fpage>8</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1046/j.1528-1157.2001.042suppl.3008.x</pub-id>
<pub-id pub-id-type="pmid">11520315</pub-id>
</element-citation>
</ref>
<ref id="b4-04mjms25062018_oa1">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thom</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Review: hippocampal sclerosis in epilepsy: a neuropathology review</article-title>
<source/>Neuropathol Appl Neurobiol
          <year>2014</year>
<volume>40</volume>
<issue>5</issue>
<fpage>520</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1111/nan.12150</pub-id>
<pub-id pub-id-type="pmid">24762203</pub-id>
</element-citation>
</ref>
<ref id="b5-04mjms25062018_oa1">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soukupová</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Binaschi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Falcicchia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zucchini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Roncon</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Palma</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy</article-title>
<source/>Exp Neurol
          <year>2014</year>
<volume>257</volume>
<fpage>39</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2014.04.014</pub-id>
<pub-id pub-id-type="pmid">24768627</pub-id>
</element-citation>
</ref>
<ref id="b6-04mjms25062018_oa1">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kuruba</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions</article-title>
<source/>Int J Mol Sci
          <year>2013</year>
<volume>14</volume>
<issue>9</issue>
<fpage>18284</fpage>
<lpage>18318</lpage>
<pub-id pub-id-type="doi">10.3390/ijms140918284</pub-id>
<pub-id pub-id-type="pmid">24013377</pub-id>
</element-citation>
</ref>
<ref id="b7-04mjms25062018_oa1">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carney</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Prowse</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</name>
</person-group>
<article-title>Epilepsy syndromes in children</article-title>
<source/>Aust Fam Physician
          <year>2005</year>
<volume>34</volume>
<issue>12</issue>
<fpage>1009</fpage>
<lpage>1015</lpage>
<pub-id pub-id-type="pmid">16333482</pub-id>
</element-citation>
</ref>
<ref id="b8-04mjms25062018_oa1">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaila</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ruusuvuori</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Seja</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Voipio</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Puskarjov</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>GABA actions and ionic plasticity in epilepsy</article-title>
<source/>Curr Opin Neurobiol
          <year>2014</year>
<volume>26</volume>
<fpage>34</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2013.11.004</pub-id>
<pub-id pub-id-type="pmid">24650502</pub-id>
</element-citation>
</ref>
<ref id="b9-04mjms25062018_oa1">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rugg-Gunn</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hjalgrim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Seyal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bateman</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>From unwitnessed fatality to witnessed rescue: nonpharmacologic interventions in sudden unexpected death in epilepsy</article-title>
<source/>Epilepsia
          <year>2016</year>
<volume>57</volume>
<issue>S1</issue>
<fpage>26</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1111/epi.13231</pub-id>
<pub-id pub-id-type="pmid">26749014</pub-id>
</element-citation>
</ref>
<ref id="b10-04mjms25062018_oa1">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Todd</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Boosalis</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Burzycki</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Steinman</surname>
<given-names>MQ</given-names>
</name>
<name>
<surname>Hester</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Shuster</surname>
<given-names>PW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Towards neuronal organoids: a method for long-term culturing of high-density hippocampal neurons</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>4</issue>
<fpage>e58996</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0058996</pub-id>
<pub-id pub-id-type="pmid">23634200</pub-id>
</element-citation>
</ref>
<ref id="b11-04mjms25062018_oa1">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaech</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Banker</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Culturing hippocampal neurons</article-title>
<source/>Nat Protoc
          <year>2006</year>
<volume>1</volume>
<issue>5</issue>
<fpage>2406</fpage>
<lpage>2415</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2006.356</pub-id>
<pub-id pub-id-type="pmid">17406484</pub-id>
</element-citation>
</ref>
<ref id="b12-04mjms25062018_oa1">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lévesque</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Avoli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Animal models of temporal lobe epilepsy following systemic chemoconvulsant administration</article-title>
<source/>J Neurosci Methods
          <year>2016</year>
<volume>260</volume>
<fpage>45</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneumeth.2015.03.009</pub-id>
<pub-id pub-id-type="pmid">25769270</pub-id>
</element-citation>
</ref>
<ref id="b13-04mjms25062018_oa1">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lucchi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vinet</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gualtieri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Marinelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Torsello</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?</article-title>
<source/>Curr Med Chem
          <year>2014</year>
<volume>21</volume>
<issue>6</issue>
<fpage>663</fpage>
<lpage>688</lpage>
<pub-id pub-id-type="doi">10.2174/0929867320666131119152201</pub-id>
<pub-id pub-id-type="pmid">24251566</pub-id>
</element-citation>
</ref>
<ref id="b14-04mjms25062018_oa1">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lévesque</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Avoli</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The kainic acid model of temporal lobe epilepsy</article-title>
<source/>Neurosci Biobehav Rev
          <year>2013</year>
<volume>37</volume>
<issue>10</issue>
<fpage>2887</fpage>
<lpage>2899</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.10.011</pub-id>
<pub-id pub-id-type="pmid">24184743</pub-id>
</element-citation>
</ref>
<ref id="b15-04mjms25062018_oa1">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohd Sairazi</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Sirajudeen</surname>
<given-names>KNS</given-names>
</name>
<name>
<surname>Asari</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Muzaimi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mummedy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sulaiman</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Kainic acid-induced excitotoxicity experimental model: protective merits of natural products and plant extracts</article-title>
<source/>Evid Based Complement Alternat Med
          <year>2015</year>
<volume>2015</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1155/2015/972623</pub-id>
</element-citation>
</ref>
<ref id="b16-04mjms25062018_oa1">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Z-L</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Z-Q</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lysosomal enzyme cathepsin B is involved in kainic acid-induced excitotoxicity in rat striatum</article-title>
<source/>Brain Res
          <year>2006</year>
<volume>1071</volume>
<issue>1</issue>
<fpage>245</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2005.10.074</pub-id>
<pub-id pub-id-type="pmid">16409994</pub-id>
</element-citation>
</ref>
<ref id="b17-04mjms25062018_oa1">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Śmiałowska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gołembiowska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kajta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zięba</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dziubina</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Domin</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus</article-title>
<source/>Neurotox Res
          <year>2011</year>
<volume>21</volume>
<issue>4</issue>
<fpage>379</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1007/s12640-011-9293-4</pub-id>
<pub-id pub-id-type="pmid">22144346</pub-id>
</element-citation>
</ref>
<ref id="b18-04mjms25062018_oa1">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J-J</given-names>
</name>
<name>
<surname>Haberberger</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ProBDNF collapses neurite outgrowth of primary neurons by activating RhoA</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>4</issue>
<fpage>e35883</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0035883</pub-id>
<pub-id pub-id-type="pmid">22558255</pub-id>
</element-citation>
</ref>
<ref id="b19-04mjms25062018_oa1">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bevinahal</surname>
<given-names>PKK</given-names>
</name>
<name>
<surname>Venugopal</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yencharla</surname>
<given-names>HCPS</given-names>
</name>
<name>
<surname>Chandanala</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Trichur</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Talakad</surname>
<given-names>SN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Conditioned medium reconditions hippocampal neurons against kainic acid induced excitotoxicity: an in vitro study</article-title>
<source/>J Toxicol
          <year>2014</year>
<volume>2014</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1155/2014/194967</pub-id>
</element-citation>
</ref>
<ref id="b20-04mjms25062018_oa1">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holopainen</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Mechanisms of kainate-induced region-specific neuronal death in immature organotypic hippocampal slice cultures</article-title>
<source/>Neurochem Int
          <year>2004</year>
<volume>45</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2004.01.005</pub-id>
<pub-id pub-id-type="pmid">15082216</pub-id>
</element-citation>
</ref>
<ref id="b21-04mjms25062018_oa1">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuruba</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hattiangady</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shetty</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy</article-title>
<source/>Epilepsy Behav
          <year>2009</year>
<volume>14</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1016/j.yebeh.2008.08.020</pub-id>
<pub-id pub-id-type="pmid">18796338</pub-id>
</element-citation>
</ref>
<ref id="b22-04mjms25062018_oa1">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ernfors</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K-F</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Mice lacking brain-derived neurotrophic factor develop with sensory deficits</article-title>
<source/>Nature
          <year>1994</year>
<volume>368</volume>
<issue>6467</issue>
<fpage>147</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1038/368147a0</pub-id>
<pub-id pub-id-type="pmid">8139657</pub-id>
</element-citation>
</ref>
<ref id="b23-04mjms25062018_oa1">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kokaia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ernfors</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kokaia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Elmér</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lindvall</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Suppressed Epileptogenesis in BDNF Mutant Mice</article-title>
<source/>Exp Neurol
          <year>1995</year>
<volume>133</volume>
<issue>2</issue>
<fpage>215</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1006/exnr.1995.1024</pub-id>
<pub-id pub-id-type="pmid">7649227</pub-id>
</element-citation>
</ref>
<ref id="b24-04mjms25062018_oa1">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lähteinen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saarelainen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nissinen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Koponen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Castrén</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Decreased BDNF signalling in transgenic mice reduces epileptogenesis</article-title>
<source/>Eur J Neurosci
          <year>2002</year>
<volume>15</volume>
<issue>4</issue>
<fpage>721</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1046/j.1460-9568.2002.01897.x</pub-id>
<pub-id pub-id-type="pmid">11886452</pub-id>
</element-citation>
</ref>
<ref id="b25-04mjms25062018_oa1">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sleiman</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Al-Haddad</surname>
<given-names>R</given-names>
</name>
<name>
<surname>El Hayek</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Abou Haidar</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Stringer</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate</article-title>
<source/>eLife
          <year>2016</year>
<volume>5</volume>
<fpage>e15092</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.15092</pub-id>
<pub-id pub-id-type="pmid">27253067</pub-id>
</element-citation>
</ref>
<ref id="b26-04mjms25062018_oa1">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patapoutian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Reichardt</surname>
<given-names>LF</given-names>
</name>
</person-group>
<article-title>Trk receptors: mediators of neurotrophin action</article-title>
<source/>Curr Opin Neurobiol
          <year>2001</year>
<volume>11</volume>
<issue>3</issue>
<fpage>272</fpage>
<lpage>280</lpage>
<pub-id pub-id-type="doi">10.1016/S0959-4388(00)00208-7</pub-id>
<pub-id pub-id-type="pmid">11399424</pub-id>
</element-citation>
</ref>
<ref id="b27-04mjms25062018_oa1">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gottschalk</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Schnell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zang</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB</article-title>
<source/>J Neurosci
          <year>2000</year>
<volume>20</volume>
<issue>18</issue>
<fpage>6888</fpage>
<lpage>6897</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-18-06888.2000</pub-id>
<pub-id pub-id-type="pmid">10995833</pub-id>
</element-citation>
</ref>
<ref id="b28-04mjms25062018_oa1">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>PV</given-names>
</name>
</person-group>
<article-title>An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus</article-title>
<source/>Int J Pept
          <year>2011</year>
<volume>2011</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1155/2011/654085</pub-id>
</element-citation>
</ref>
<ref id="b29-04mjms25062018_oa1">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porcher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hatchett</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Longbottom</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>McAinch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sihra</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Positive feedback regulation between γ-Aminobutyric acid type A (GABA<sub>A</sub>) receptor signaling and Brain-derived Neurotrophic Factor (BDNF) release in developing neurons</article-title>
<source/>J Biol Chem
          <year>2011</year>
<volume>286</volume>
<issue>24</issue>
<fpage>21667</fpage>
<lpage>21677</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.201582</pub-id>
<pub-id pub-id-type="pmid">21474450</pub-id>
</element-citation>
</ref>
<ref id="b30-04mjms25062018_oa1">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edelmann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Leßmann</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Brigadski</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity</article-title>
<source/>Neuropharmacology
          <year>2014</year>
<volume>76</volume>
<fpage>610</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.05.043</pub-id>
<pub-id pub-id-type="pmid">23791959</pub-id>
</element-citation>
</ref>
<ref id="b31-04mjms25062018_oa1">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elmariah</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Crumling</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Balice-Gordon</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Postsynaptic TrkB-mediated signaling modulates excitatory and inhibitory neurotransmitter receptor clustering at hippocampal synapses</article-title>
<source/>J Neurosci
          <year>2004</year>
<volume>24</volume>
<issue>10</issue>
<fpage>2380</fpage>
<lpage>2393</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4112-03.2004</pub-id>
<pub-id pub-id-type="pmid">15014113</pub-id>
</element-citation>
</ref>
<ref id="b32-04mjms25062018_oa1">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Copenhagen</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Badurek</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Minichiello</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ranscht</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TrkB (Tropomyosin-Related Kinase B) controls the assembly and maintenance of GABAergic synapses in the cerebellar cortex</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<issue>8</issue>
<fpage>2769</fpage>
<lpage>2780</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4991-10.2011</pub-id>
<pub-id pub-id-type="pmid">21414899</pub-id>
</element-citation>
</ref>
<ref id="b33-04mjms25062018_oa1">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rico</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Reichardt</surname>
<given-names>LF</given-names>
</name>
</person-group>
<article-title>TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum</article-title>
<source/>Nat Neurosci
          <year>2002</year>
<volume>5</volume>
<issue>3</issue>
<fpage>225</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="doi">10.1038/nn808</pub-id>
<pub-id pub-id-type="pmid">11836532</pub-id>
</element-citation>
</ref>
<ref id="b34-04mjms25062018_oa1">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsuki</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Inhibition of GABA<sub>A</sub> synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus</article-title>
<source/>J Neurosci
          <year>1997</year>
<volume>17</volume>
<issue>9</issue>
<fpage>2959</fpage>
<lpage>2966</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-09-02959.1997</pub-id>
<pub-id pub-id-type="pmid">9096132</pub-id>
</element-citation>
</ref>
<ref id="b35-04mjms25062018_oa1">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ohba</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ikegaya</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons</article-title>
<source/>J Neurosci
          <year>2002</year>
<volume>22</volume>
<issue>17</issue>
<fpage>7580</fpage>
<lpage>7585</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-17-07580.2002</pub-id>
<pub-id pub-id-type="pmid">12196581</pub-id>
</element-citation>
</ref>
<ref id="b36-04mjms25062018_oa1">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldelli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor enhances GABA release probability and nonuniform distribution of N- and P/Q-Type channels on release sites of hippocampal inhibitory synapses</article-title>
<source/>J Neurosci
          <year>2005</year>
<volume>25</volume>
<issue>13</issue>
<fpage>3358</fpage>
<lpage>3368</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4227-04.2005</pub-id>
<pub-id pub-id-type="pmid">15800191</pub-id>
</element-citation>
</ref>
<ref id="b37-04mjms25062018_oa1">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinrich</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lähteinen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Anne-Marie</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Häussler</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increase in BDNF-mediated TrkB signaling promotes epileptogenesis in a mouse model of mesial temporal lobe epilepsy</article-title>
<source/>Neurobiol Dis
          <year>2011</year>
<volume>42</volume>
<issue>1</issue>
<fpage>35</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2011.01.001</pub-id>
<pub-id pub-id-type="pmid">21220014</pub-id>
</element-citation>
</ref>
<ref id="b38-04mjms25062018_oa1">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palma</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Limatola</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Trettel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Arcella</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cantore</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BDNF modulates GABA<sub>A</sub> receptors microtransplanted from the human epileptic brain to Xenopus oocytes</article-title>
<source/>Proceedings of the National Academy of Sciences
          <year>2005</year>
<volume>102</volume>
<issue>5</issue>
<fpage>1667</fpage>
<lpage>1672</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0409442102</pub-id>
</element-citation>
</ref>
<ref id="b39-04mjms25062018_oa1">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croll</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Suri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Compton</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Yancopoulos</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Lindsay</surname>
<given-names>RM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex</article-title>
<source/>Neuroscience
          <year>1999</year>
<volume>93</volume>
<issue>4</issue>
<fpage>1491</fpage>
<lpage>1506</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(99)00296-1</pub-id>
<pub-id pub-id-type="pmid">10501474</pub-id>
</element-citation>
</ref>
<ref id="b40-04mjms25062018_oa1">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X-P</given-names>
</name>
<name>
<surname>Kotloski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nef</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Luikart</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>McNamara</surname>
<given-names>JO</given-names>
</name>
</person-group>
<article-title>Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the Kindling model</article-title>
<source/>Neuron
          <year>2004</year>
<volume>43</volume>
<issue>1</issue>
<fpage>31</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2004.06.019</pub-id>
<pub-id pub-id-type="pmid">15233915</pub-id>
</element-citation>
</ref>
<ref id="b41-04mjms25062018_oa1">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathew</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Hablitz</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Calcium release via activation of presynaptic IP3 receptors contributes to kainate-induced IPSC facilitation in rat neocortex</article-title>
<source/>Neuropharmacology
          <year>2008</year>
<volume>55</volume>
<issue>1</issue>
<fpage>106</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.05.005</pub-id>
<pub-id pub-id-type="pmid">18508095</pub-id>
</element-citation>
</ref>
<ref id="b42-04mjms25062018_oa1">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Poo</surname>
<given-names>M-m</given-names>
</name>
</person-group>
<article-title>Neurotrophin regulation of neural circuit development and function</article-title>
<source/>Nat Rev Neurosci
          <year>2012</year>
<volume>14</volume>
<issue>1</issue>
<fpage>7</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3379</pub-id>
</element-citation>
</ref>
<ref id="b43-04mjms25062018_oa1">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshii</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Constantine-Paton</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Postsynaptic localization of PSD-95 is regulated by all three pathways downstream of TrkB signaling</article-title>
<source/>Front Synaptic Neurosci
          <year>2014</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.3389/fnsyn.2014.00006</pub-id>
<pub-id pub-id-type="pmid">24478696</pub-id>
</element-citation>
</ref>
<ref id="b44-04mjms25062018_oa1">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>YR</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>D-S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Seok</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Follo</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Cocco</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Primary phospholipase C and brain disorders</article-title>
<source/>Adv Biol Regul
          <year>2016</year>
<volume>61</volume>
<fpage>80</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1016/j.jbior.2015.11.003</pub-id>
<pub-id pub-id-type="pmid">26639088</pub-id>
</element-citation>
</ref>
<ref id="b45-04mjms25062018_oa1">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagarkatti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Deshpande</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>DeLorenzo</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture</article-title>
<source/>Neurosci Lett
          <year>2008</year>
<volume>436</volume>
<issue>3</issue>
<fpage>289</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2008.02.076</pub-id>
<pub-id pub-id-type="pmid">18406528</pub-id>
</element-citation>
</ref>
<ref id="b46-04mjms25062018_oa1">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelson</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M-K</given-names>
</name>
<name>
<surname>Hongpaisan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alkon</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair</article-title>
<source/>Eur J Pharmacol
          <year>2008</year>
<volume>585</volume>
<issue>1</issue>
<fpage>76</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2008.01.051</pub-id>
<pub-id pub-id-type="pmid">18402935</pub-id>
</element-citation>
</ref>
<ref id="b47-04mjms25062018_oa1">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biffi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Regalia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Menegon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ferrigno</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pedrocchi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The influence of neuronal density and maturation on network activity of hippocampal cell cultures: a methodological study</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>12</issue>
<fpage>e83899</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0083899</pub-id>
<pub-id pub-id-type="pmid">24386305</pub-id>
</element-citation>
</ref>
<ref id="b48-04mjms25062018_oa1">
<label>48</label>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<name>
<surname>Labno</surname>
<given-names>C</given-names>
</name>
</person-group>
<source/>Two ways to count cells with ImageJ
          <comment>Retrieved from: <ext-link ext-link-type="uri" xlink:href="https://digital.bsd.uchicago.edu/docs/cell_counting_automated_and_manual.pdf">https://digital.bsd.uchicago.edu/docs/cell_counting_automated_and_manual.pdf</ext-link></comment>
</element-citation>
</ref>
<ref id="b49-04mjms25062018_oa1">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaneko</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dailey</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vale</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Tajiri</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Borlongan</surname>
<given-names>CV</given-names>
</name>
</person-group>
<article-title>Kainic acid-induced Golgi complex fragmentation/dispersal shifts the proteolysis of Reelin in primary rat neuronal cells: an in vitro model of early stage epilepsy</article-title>
<source/>Mol Neurobiol
          <year>2015</year>
<volume>53</volume>
<issue>3</issue>
<fpage>1874</fpage>
<lpage>1883</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-015-9126-1</pub-id>
<pub-id pub-id-type="pmid">25790952</pub-id>
</element-citation>
</ref>
<ref id="b50-04mjms25062018_oa1">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hancock</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>A facile method for simultaneously measuring neuronal cell viability and neurite outgrowth</article-title>
<source/>Curr Chem Genomics Transl Med
          <year>2015</year>
<volume>9</volume>
<issue>1</issue>
<fpage>6</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.2174/2213988501509010006</pub-id>
<pub-id pub-id-type="pmid">25853055</pub-id>
</element-citation>
</ref>
<ref id="b51-04mjms25062018_oa1">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meijering</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sarria</surname>
<given-names>JCF</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hirling</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Unser</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images</article-title>
<source/>Cytometry
          <year>2004</year>
<volume>58A</volume>
<issue>2</issue>
<fpage>167</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1002/cyto.a.20022</pub-id>
</element-citation>
</ref>
<ref id="b52-04mjms25062018_oa1">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeyeodu</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Gilyazova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ibeanu</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>A rapid, inexpensive high throughput screen method for neurite outgrowth</article-title>
<source/>Curr Chem Genomics
          <year>2010</year>
<volume>4</volume>
<fpage>74</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.2174/1875397301004010074</pub-id>
<pub-id pub-id-type="pmid">21347208</pub-id>
</element-citation>
</ref>
<ref id="b53-04mjms25062018_oa1">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>S-Y</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>C-Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H-L</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>T-W</given-names>
</name>
<name>
<surname>Charoenkwan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>NeurphologyJ: an automatic neuronal morphology quantification method and its application in pharmacological discovery</article-title>
<source/>BMC Bioinformatics
          <year>2011</year>
<volume>12</volume>
<issue>1</issue>
<fpage>230</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-12-230</pub-id>
<pub-id pub-id-type="pmid">21651810</pub-id>
</element-citation>
</ref>
<ref id="b54-04mjms25062018_oa1">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bywood</surname>
<given-names>PT</given-names>
</name>
</person-group>
<article-title>Neurotoxic effects of kainic acid on Substantia Nigra neurons in rat brain slices</article-title>
<source/>Exp Neurol
          <year>1997</year>
<volume>146</volume>
<issue>2</issue>
<fpage>546</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1006/exnr.1997.6578</pub-id>
<pub-id pub-id-type="pmid">9270066</pub-id>
</element-citation>
</ref>
<ref id="b55-04mjms25062018_oa1">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bywood</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices</article-title>
<source/>Exp Neurol
          <year>2000</year>
<volume>161</volume>
<issue>1</issue>
<fpage>306</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1006/exnr.1999.7259</pub-id>
<pub-id pub-id-type="pmid">10683296</pub-id>
</element-citation>
</ref>
<ref id="b56-04mjms25062018_oa1">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marx</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Häussler</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Differential vulnerability of interneurons in the epileptic hippocampus</article-title>
<source/>Front Cell Neurosci
          <year>2013</year>
<volume>167</volume>
<issue>7</issue>
<fpage>1</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.3389/fncel.2013.00167</pub-id>
</element-citation>
</ref>
<ref id="b57-04mjms25062018_oa1">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Schwaderlapp</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Heining</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Häussler</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Korvink</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>von Elverfeldt</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early tissue damage and microstructural reorganization predict disease severity in experimental epilepsy</article-title>
<source/>eLife
          <year>2017</year>
<volume>6</volume>
<fpage>e25742</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.25742</pub-id>
<pub-id pub-id-type="pmid">28746029</pub-id>
</element-citation>
</ref>
<ref id="b58-04mjms25062018_oa1">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor and epilepsy-a missing link?</article-title>
<source/>Epilepsy Curr
          <year>2005</year>
<volume>5</volume>
<issue>3</issue>
<fpage>83</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1111/j.1535-7511.2005.05312.x</pub-id>
<pub-id pub-id-type="pmid">16145610</pub-id>
</element-citation>
</ref>
<ref id="b59-04mjms25062018_oa1">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sperk</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wieselthaler-Hölzl</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pirker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tasan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Strasser</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Drexel</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glutamate decarboxylase67 is expressed in hippocampal mossy fibers of temporal lobe epilepsy patients</article-title>
<source/>Hippocampus
          <year>2011</year>
<volume>22</volume>
<issue>3</issue>
<fpage>590</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.20923</pub-id>
<pub-id pub-id-type="pmid">21509853</pub-id>
</element-citation>
</ref>
<ref id="b60-04mjms25062018_oa1">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Piechowicz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A simplified method for ultra-low density, long-term primary hippocampal neuron culture</article-title>
<source/>J Vis Exp
          <year>2016</year>
<volume>109</volume>
<fpage>e53797</fpage>
</element-citation>
</ref>
<ref id="b61-04mjms25062018_oa1">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rajput</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Sastry</surname>
<given-names>BR</given-names>
</name>
</person-group>
<article-title>Regulation of GABA equilibrium potential by mGluRs in rat hippocampal CA1 neurons</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<issue>9</issue>
<fpage>e0138215</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0138215</pub-id>
<pub-id pub-id-type="pmid">26389591</pub-id>
</element-citation>
</ref>
<ref id="b62-04mjms25062018_oa1">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloss</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>RG</given-names>
</name>
</person-group>
<article-title>Hippocampal kainate receptors</article-title>
<source/>Vitamins &amp; Hormones
          <year>2010</year>
<volume>82</volume>
<fpage>167</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1016/S0083-6729(10)82009-6</pub-id>
<pub-id pub-id-type="pmid">20472138</pub-id>
</element-citation>
</ref>
<ref id="b63-04mjms25062018_oa1">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisahn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>McBain</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>The kainate receptor subunit GluR6 mediates metabotropic regulation of the slow and medium AHP currents in mouse hippocampal neurones</article-title>
<source/>J Physiol
          <year>2004</year>
<volume>562</volume>
<issue>1</issue>
<fpage>199</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.077412</pub-id>
<pub-id pub-id-type="pmid">15539395</pub-id>
</element-citation>
</ref>
<ref id="b64-04mjms25062018_oa1">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Folsom</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>GABA receptor subunit distribution and FMRP–mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism</article-title>
<source/>Schizophr Res
          <year>2015</year>
<volume>167</volume>
<issue>1–3</issue>
<fpage>42</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2014.10.010</pub-id>
<pub-id pub-id-type="pmid">25432637</pub-id>
</element-citation>
</ref>
<ref id="b65-04mjms25062018_oa1">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Y-J</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T-H</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aberrant glutamate receptor 5 expression in temporal lobe epilepsy lesions</article-title>
<source/>Brain Res
          <year>2010</year>
<volume>1311</volume>
<fpage>166</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2009.11.024</pub-id>
<pub-id pub-id-type="pmid">19941835</pub-id>
</element-citation>
</ref>
<ref id="b66-04mjms25062018_oa1">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staak</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pape</surname>
<given-names>HC</given-names>
</name>
</person-group>
<article-title>Contribution of GABA(A) and GABA(B) receptors to thalamic neuronal activity during spontaneous absence seizures in rats</article-title>
<source/>J Neurosci
          <year>2001</year>
<volume>21</volume>
<issue>4</issue>
<fpage>1378</fpage>
<lpage>1384</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-04-01378.2001</pub-id>
<pub-id pub-id-type="pmid">11160409</pub-id>
</element-citation>
</ref>
<ref id="b67-04mjms25062018_oa1">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charpier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Leresche</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Deniau</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Mahon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Crunelli</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>On the putative contribution of GABA(B) receptors to the electrical events occurring during spontaneous spike and wave discharges</article-title>
<source/>Neuropharmacology
          <year>1999</year>
<volume>38</volume>
<issue>11</issue>
<fpage>1699</fpage>
<lpage>1706</lpage>
<pub-id pub-id-type="doi">10.1016/S0028-3908(99)00139-2</pub-id>
<pub-id pub-id-type="pmid">10587086</pub-id>
</element-citation>
</ref>
<ref id="b68-04mjms25062018_oa1">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snead</surname>
<given-names>OC</given-names>
<suffix>3rd</suffix>
</name>
</person-group>
<article-title>Basic mechanisms of generalized absence seizures</article-title>
<source/>Ann Neurol
          <year>1995</year>
<volume>37</volume>
<issue>2</issue>
<fpage>146</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">7847856</pub-id>
</element-citation>
</ref>
<ref id="b69-04mjms25062018_oa1">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCormick</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Bal</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Sleep and arousal: thalamocortical mechanisms</article-title>
<source/>Annu Rev Neurosci
          <year>1997</year>
<volume>20</volume>
<fpage>185</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="pmid">9056712</pub-id>
</element-citation>
</ref>
<ref id="b70-04mjms25062018_oa1">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Conditional downregulation of brain-derived neurotrophic factor and tyrosine kinase receptor B blocks epileptogenesis in the human temporal lobe epilepsy hippocampus</article-title>
<source/>Neurol India
          <year>2010</year>
<volume>58</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.4103/0028-3886.60392</pub-id>
<pub-id pub-id-type="pmid">20228460</pub-id>
</element-citation>
</ref>
<ref id="b71-04mjms25062018_oa1">
<label>71</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>McNamara</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</name>
</person-group>
<article-title>Temporal lobe epilepsy and the BDNF receptor, TrkB</article-title>
<source/>Jasper’s basic mechanisms of the epilepsies [Internet]
          <publisher-name>Oxford University Press</publisher-name>
<year>2012</year>
<fpage>514</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="doi">10.1093/med/9780199746545.003.0039</pub-id>
</element-citation>
</ref>
<ref id="b72-04mjms25062018_oa1">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lähteinen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pitkänen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Knuuttila</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Törönen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Castrén</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor signaling modifies hippocampal gene expression during epileptogenesis in transgenic mice</article-title>
<source/>Eur J Neurosci
          <year>2004</year>
<volume>19</volume>
<issue>12</issue>
<fpage>3245</fpage>
<lpage>3254</lpage>
<pub-id pub-id-type="doi">10.1111/j.0953-816X.2004.03440.x</pub-id>
<pub-id pub-id-type="pmid">15217381</pub-id>
</element-citation>
</ref>
<ref id="b73-04mjms25062018_oa1">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volosin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Trotter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cragnolini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kenchappa</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Light</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hempstead</surname>
<given-names>BL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of proneurotrophins and activation of p75NTRmediated apoptosis via neurotrophin receptor-interacting factor in hippocampal neurons after seizures</article-title>
<source/>J Neurosci
          <year>2008</year>
<volume>28</volume>
<issue>39</issue>
<fpage>9870</fpage>
<lpage>9879</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2841-08.2008</pub-id>
<pub-id pub-id-type="pmid">18815271</pub-id>
</element-citation>
</ref>
<ref id="b74-04mjms25062018_oa1">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>VonDran</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>LaFrancois</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Padow</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Milner</surname>
<given-names>TA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>p75NTR, but not proNGF, is upregulated following status epilepticus in mice</article-title>
<source/>ASN Neuro
          <year>2014</year>
<volume>6</volume>
<issue>5</issue>
<comment>175909141455218</comment>
<pub-id pub-id-type="doi">10.1177/1759091414552185</pub-id>
</element-citation>
</ref>
<ref id="b75-04mjms25062018_oa1">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Binder</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</name>
</person-group>
<article-title>Mini review</article-title>
<source/>Growth Factors
          <year>2004</year>
<volume>22</volume>
<issue>3</issue>
<fpage>123</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1080/08977190410001723308</pub-id>
<pub-id pub-id-type="pmid">15518235</pub-id>
</element-citation>
</ref>
<ref id="b76-04mjms25062018_oa1">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Mechanisms of neurotrophin receptor vesicular transport</article-title>
<source/>J Neurobiol
          <year>2003</year>
<volume>58</volume>
<issue>2</issue>
<fpage>244</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="doi">10.1002/neu.10321</pub-id>
</element-citation>
</ref>
<ref id="b77-04mjms25062018_oa1">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bathina</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>UN</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor and its clinical implications</article-title>
<source/>Arch Med Sci
          <year>2015</year>
<volume>6</volume>
<fpage>1164</fpage>
<lpage>1178</lpage>
<pub-id pub-id-type="doi">10.5114/aoms.2015.56342</pub-id>
</element-citation>
</ref>
<ref id="b78-04mjms25062018_oa1">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Krimm</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>Developmental expression of Bdnf, Ntf4/5, and TrkB in the mouse peripheral taste system</article-title>
<source/>Dev Dyn
          <year>2010</year>
<volume>239</volume>
<issue>10</issue>
<fpage>2637</fpage>
<lpage>2646</lpage>
<pub-id pub-id-type="doi">10.1002/dvdy.22412</pub-id>
<pub-id pub-id-type="pmid">21038447</pub-id>
</element-citation>
</ref>
<ref id="b79-04mjms25062018_oa1">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Huang Yang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X-P</given-names>
</name>
<name>
<surname>Joshi Rasesh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>McNamara James</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>A peptide uncoupling BDNF receptor TrkB from phospholipase Cγ1 prevents epilepsy induced by status epilepticus</article-title>
<source/>Neuron
          <year>2015</year>
<volume>88</volume>
<issue>3</issue>
<fpage>484</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.032</pub-id>
<pub-id pub-id-type="pmid">26481038</pub-id>
</element-citation>
</ref>
<ref id="b80-04mjms25062018_oa1">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baba</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Onga</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kakizawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ohyama</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yasuda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Otsubo</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Involvement of the neuronal phosphotyrosine signal adaptor N-Shc in kainic acid-induced epileptiform activity</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/srep27511</pub-id>
<pub-id pub-id-type="pmid">28442746</pub-id>
</element-citation>
</ref>
<ref id="b81-04mjms25062018_oa1">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>RMF</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>de Cerqueira</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>El-Bachá</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives</article-title>
<source/>Oxid Med Cell Longev
          <year>2011</year>
<volume>2011</volume>
<fpage>1</fpage>
<lpage>14</lpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-04mjms25062018_oa1" position="float">
<label>Figure 1</label>
<caption>
<p>Morphological changes of E-18 rat hippocampal neuron culture. (A) Inverted microscopy images of hippocampal neuronal culture on different days-in-vitro (DIV) at 10× magnification using a Dino-Eye camera. A–F Morphological changes of the cell were observed at every 3 to 4 days of DIV 1; DIV-5; DIV 9; DIV-12; DIV 16; DIV 21. Scale bar represents 200 μm; (B) Inverted microscopy images of hippocampal neuronal culture at DIV12 at 10× magnification using a Canon Ds126191 microscope. Morphological changes of the cell were observed and captured in the neuron culture without treatment as a control condition, and culture with KA treatment as the treatment conditions (KA1: 30 min KA treatment; KA2: 60 min KA treatment; KA3: 90 min KA treatment). Scale bar represents 200 μm</p>
</caption>
<graphic xlink:href="04mjms25062018_oa1f1"></graphic>
</fig>
<fig id="f2-04mjms25062018_oa1" position="float">
<label>Figure 2</label>
<caption>
<p>(A) Measurement of cell viability in RFU units for the control group and treatment groups (KA1, KA2 and KA3, incubated with 0.05 μm KA for 30, 60 and 90 min, respectively). (B) Neurite outgrowth density in RFU units in the control group and treatment groups (KA1, KA2, and KA3, incubated with 0.05 μm KA for 30, 60 and 90 min, respectively)</p>
</caption>
<graphic xlink:href="04mjms25062018_oa1f2"></graphic>
</fig>
<fig id="f3-04mjms25062018_oa1" position="float">
<label>Figure 3</label>
<caption>
<p>(A) Immunofluorescence images of hippocampal neuronal culture stained with primary antibody: anti-BDNF (Abcam) and secondary antibody Alexa Fluor 488 (Invitrogen) co-stained with Dapi (Invitrogen) for control; KA1: hippocampal neuronal culture + KA incubated 30 min; KA2: hippocampal neuronal culture + KA incubated 60 min; KA3 hippocampal neuronal culture + KA incubated 90 min. The scale bar represents 100 μM. (B) Intensity of BDNF stained rat hippocampal neuronal culture with control group (without KA), KA1 (30 min KA incubation), KA2 (60 min KA incubation), KA3 (90 min KA incubation). (C) Number of BDNF stained particles count in rat hippocampal neuronal culture with treatment: control group (without KA), KA1 (30 min KA incubation), KA2 (60 min KA incubation), KA3 (90 min KA incubation)</p>
</caption>
<graphic xlink:href="04mjms25062018_oa1f3"></graphic>
</fig>
<fig id="f4-04mjms25062018_oa1" position="float">
<label>Figure 4</label>
<caption>
<p>KA inhibited TrkB expression. (A) Immunofluorescence images of hippocampal neuronal culture stained with primary antibody: Anti-TrkB (Abcam) and secondary antibody Alexa Fluor 488 (Invitrogen) co-stained with Dapi (Invitrogen). (B) Immunofluorescence intensity from control and cell culture with KA treatment; KA1: 30 min KA treated neuron culture; KA2: 60 min KA treated neuron culture; KA3: 90 min KA treated neuron culture. (C) Number of TrkB stained particles count in rat hippocampal neuronal culture with treatment: control group (without KA), KA1 (30 min KA incubation), KA2 (60 min KA incubation), KA3 (90 min KA incubation)</p>
</caption>
<graphic xlink:href="04mjms25062018_oa1f4"></graphic>
</fig>
<fig id="f5-04mjms25062018_oa1" position="float">
<label>Figure 5</label>
<caption>
<p>IP3R induced after KA introduction. (A) Immunofluorescence images of hippocampal neuronal culture stained with primary antibody: Anti-IP3R (Abcam) and secondary antibody Alexa Fluor 594 (Invitrogen) (B) Immunofluorescence intensity from control and cell culture with KA treatment; KA1: 30 min KA treated neuron culture; KA2: 60 min KA treated neuron culture; KA3: 90 min KA treated neuron culture. (C) Number of IP3 stained particles count in rat hippocampal neuronal culture with treatment: control group (without KA), KA1 (30 min KA incubation), KA2 (60 min KA incubation), KA3 (90 min KA incubation)</p>
</caption>
<graphic xlink:href="04mjms25062018_oa1f5"></graphic>
</fig>
<fig id="f6-04mjms25062018_oa1" position="float">
<label>Figure 6</label>
<caption>
<p>KA did not significantly affect GABA<sub>A</sub>R α-1. (A) Immunofluorescence images of hippocampal neuronal culture stained with primary antibody: anti-GABRA1 (Abcam) and secondary antibody Alexa Fluor 488 (Invitrogen) Control; KA1: hippocampal neuronal culture + KA incubated for 30 min; KA2: hippocampal neuronal culture + KA incubated for 60 min; KA3: hippocampal neuronal culture + KA incubated for 90 min. The scale bar represents 100 μM. (B) Intensity of GABRA1 stained rat hippocampal neuronal culture in the control group (without KA), KA1 (30 min KA incubation), KA2 (60 min KA incubation), KA3 (90 min KA incubation). (C) Number of GABA<sub>A</sub>R α-1 stained particles count in rat hippocampal neuronal culture with treatment: control group (without KA), KA1 (30 min KA incubation), KA2 (60 min KA incubation), KA3 (90 min KA incubation)</p>
</caption>
<graphic xlink:href="04mjms25062018_oa1f6"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>